Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

527 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
BETA PRIME: Phase I study of AdAPT-001 as monotherapy and combined with a checkpoint inhibitor in superficially accessible, treatment-refractory solid tumors.
Kesari S, Bessudo A, Gastman BR, Conley AP, Villaflor VM, Nabell LM, Madere D, Chacon E, Spencer C, Li L, Larson C, Reid T, Caroen S, Oronsky B, Stirn M, Williams J, Barve MA. Kesari S, et al. Among authors: conley ap. Future Oncol. 2022 Sep;18(29):3245-3254. doi: 10.2217/fon-2022-0481. Epub 2022 Aug 11. Future Oncol. 2022. PMID: 35950603 Free article.
BETA prime: a first-in-man phase 1 study of AdAPT-001, an armed oncolytic adenovirus for solid tumors.
Conley AP, Roland CL, Bessudo A, Gastman BR, Villaflor VM, Larson C, Reid TR, Caroen S, Oronsky B, Stirn M, Williams J, Burbano E, Coyle A, Barve MA, Wagle N, Abrouk N, Kesari S. Conley AP, et al. Cancer Gene Ther. 2024 Apr;31(4):517-526. doi: 10.1038/s41417-023-00720-0. Epub 2023 Dec 25. Cancer Gene Ther. 2024. PMID: 38146006 Free PMC article. Clinical Trial.
Predicting the Abscopal Phenomenon-Letter to the Editor.
Conley AP, Oronsky B, Caroen S, Larson C, Reid T. Conley AP, et al. Mol Cancer Ther. 2024 Feb 1;23(2):248-249. doi: 10.1158/1535-7163.MCT-23-0399. Mol Cancer Ther. 2024. PMID: 38298150 Free PMC article. No abstract available.
Cause of death in patients with lower-risk myelodysplastic syndrome.
Dayyani F, Conley AP, Strom SS, Stevenson W, Cortes JE, Borthakur G, Faderl S, O'Brien S, Pierce S, Kantarjian H, Garcia-Manero G. Dayyani F, et al. Cancer. 2010 May 1;116(9):2174-9. doi: 10.1002/cncr.24984. Cancer. 2010. PMID: 20162709 Free PMC article.
Phase 1 study of the combination of vemurafenib, carboplatin, and paclitaxel in patients with BRAF-mutated melanoma and other advanced malignancies.
Bhatty M, Kato S, Piha-Paul SA, Naing A, Subbiah V, Huang HJ, Karp DD, Tsimberidou AM, Zinner RG, Hwu WJ, Javle M, Patel SP, Hu MI, Varadhachary GR, Conley AP, Ramzanali NM, Holley VR, Kurzrock R, Meric-Bernstam F, Kwang Chae Y, Kim KB, Falchook GS, Janku F. Bhatty M, et al. Among authors: conley ap. Cancer. 2019 Feb 1;125(3):463-472. doi: 10.1002/cncr.31812. Epub 2018 Nov 1. Cancer. 2019. PMID: 30383888 Free PMC article. Clinical Trial.
527 results